This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

The World Market For Stents (Drug-Eluting And Bare Metal Product Markets In US, EU, Japan, India, China And ROW)

Table 3-1: Selected Marketed Bare Metal Stents, 2012

 

Table 3-2: Selected Bare Metal Coronary Stents, 2012

 

Table 3-3: Selected Marketed Drug-Eluting Stents, 2012

 

Table 3-4: Selected Features of Different Generations of Commercially

 

Available Drug-eluting Stents

 

CHAPTER FOUR: RECENT ADVANCES IN CORONARY STENTS

 

TECHNOLOGIES

 

Table 4-1: Selected Coronary Stents using Biodegradable Polymers, 2012

 

Table 4-2: Selected Coronary Polymer-free and Novel Coating Stents, 2012

 

Table 4-3: Selected Direct Drug Application Coronary Stents, 2012

 

Table 4-4: Selected Coronary Polymer and Drug-free Coating Stents, 2012

 

Table 4-5: Advantages and Disadvantages of Bioresorbable Stents

 

Table 4-6: Selected Bioresorbable Coronary Stents, 2012

 

Table 4-7: Selected Dedicated Bifurcation Coronary Drug-Eluting Stents, 2012

 

Table 4-8: Selected Dedicated Small Vessels Coronary Drug-Eluting Stents, 2012

 

Table 4-9: Drug Release Parameters of Selected Drug-Eluting Stents

 

CHAPTER FIVE: INDUSTRY STRUCTURE

 

Table 5-1: Industry Structure – Major Competitors and Selected

 

Marketed Products, 2012

 

Table 5-2: Significant Trends in the Coronary Stents Market, 2012

 

CHAPTER SIX: MARKET REVENUES AND FORECAST

 

Table 6-1: Coronary Stents Estimated Global Market Shares, 2011

 

Figure 6-1: Stents Market Share, 2011

 

Table 6-2: Global Market Revenues for Coronary Stents ($ Millions)

 

Figure 6-2: Global Stents Market Forecast

 

Figure 6-3: Market Breakdown by Type of Stent (BMS, DES)

 

Figure 6-4: Drug Eluting Stents Market Shre, 2011

 

Table 6-3: Global Market Revenues for Coronary Stents ($ Millions)

 

Figure 6-5: Global Market Revenues Forecast ($ Billions)Drug-Eluting Stents, 2010-2017

 

Figure 6-6: Market Breakdown by Type of Stent (BMS, DES)

 

Figure 6-7: Market Share Bare Metal Stents

 

Table 6-4: Global Market Revenues for Coronary Bare Metal Stents, 2010-2017 (Bare Metal Stent, Drug Eluding Stent, Total)

 

Figure 6-8: Bare Metal Stents Market 2010-2017

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs